|
Volumn 288, Issue 23, 2002, Pages 2967-
|
From the Centers for Disease Control and Prevention. Update: fatal and severe liver injuries associated with rifampin and pyrazinamide treatment for latent tuberculosis infection.
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PYRAZINAMIDE;
RIFAMPICIN;
TUBERCULOSTATIC AGENT;
ARTICLE;
DRUG COMBINATION;
HUMAN;
PRACTICE GUIDELINE;
TOXIC HEPATITIS;
TUBERCULOSIS;
UNITED STATES;
ANTITUBERCULAR AGENTS;
DRUG THERAPY, COMBINATION;
HEPATITIS, TOXIC;
HUMANS;
PRACTICE GUIDELINES;
PYRAZINAMIDE;
RIFAMPIN;
TUBERCULOSIS;
UNITED STATES;
|
EID: 0037132435
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.288.23.2967 Document Type: Article |
Times cited : (7)
|
References (0)
|